Healthcare Provider Scales Verint Wrap Up Bot Use to 30,000 Agents
Verint® (NASDAQ: VRNT), known as The CX Automation Company™, has announced that a leading healthcare provider is significantly expanding its deployment of the Verint Interaction Wrap Up Bot, increasing its…
Innovo Therapeutics Reports Positive Phase 2 Results for INV-001 in Post-Thyroidectomy Scar Treatment
Innovo Therapeutics Inc. has announced promising results from its Phase 2 clinical trial for INV-001, an innovative treatment for post-thyroidectomy scars. The trial, conducted across four hospitals in Korea, including…
Bio-Rad Appoints Jon DiVincenzo President and COO
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a leading provider of life science research and clinical diagnostics products, has announced the appointment of Jon DiVincenzo as President and Chief Operating…
Akron Children’s Partners with Woebot Health for Adolescent Mental Health Tool
As the youth mental health crisis worsens, Akron Children’s is preparing to introduce a new tool to help teenagers manage anxiety and depression more effectively. Akron Children’s has partnered with…
Amneal Gets FDA Approval for Propofol Injectable Emulsion Vials
Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) has announced that the U.S. Food and Drug Administration (FDA) has approved its Abbreviated New Drug Application (ANDA) for Propofol Injectable Emulsion USP in single-dose…
Alcon Reports Strong Q2 2024 Growth in Implantables and Contact Lenses
Alcon (SIX/NYSE:ALC), a global leader in eye care, announced its financial results for the second quarter and first half of 2024. In Q2 2024, the company achieved sales of $2.5…
Carilion Clinic Enhances Cardiac Care with New Philips Innovations at Crystal Spring Tower
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Carilion Clinic, a nonprofit healthcare provider serving over one million people in Virginia and West Virginia, have…
Actio Biosciences Names Dr. Dimitrios Arkilo Chief Medical Officer
Actio Biosciences, a biotechnology firm focused on utilizing a novel genetic and precision medicine platform to create therapeutics for both rare and common diseases, has appointed Dr. Dimitrios Arkilo as…
AVS and Jacobs Institute Collaborate to Speed Up Coronary and Carotid Clinical Trials
Amplitude Vascular Systems (AVS), a medical device company specializing in treating severely calcified arterial disease with its Pulse Intravascular Lithotripsy (IVL) platform, has announced a strategic partnership with the Jacobs…
Weave Wins 4th Consecutive Readers’ Choice Award for Dental Communication and Analytics
Weave (NYSE: WEAV), a top all-in-one customer experience and payments platform, has clinched its fourth consecutive Dental Product Shopper Readers’ Choice Award for both Patient Communication and Dental Analytics software.…
QuantHealth Reports $215M Returns and 85% Accuracy for Pharma
QuantHealth, an AI-driven clinical trial design firm, has successfully simulated over 100 trials, achieving 85% accuracy and notable returns on investment for pharmaceutical partners. By utilizing its proprietary technology and…
Relief Mental Health Launches TMS for Smoking Cessation in Oak Brook, IL
Relief Mental Health, a top provider of transcranial magnetic stimulation (TMS), psychedelic therapy (including SPRAVATO® and IV ketamine), psychiatry, and talk therapy, has introduced TMS for smoking cessation at its…